Carlsberg India, TMC Transformers, Ujin Pharma receive SEBI nod to float IPOs

As per the latest business developments, Danish brewing giant Carlsberg's India unit, TMC Transformers (India), Ujin Pharma, and Matangi Rubber have received regulatory clearance from SEBI to proceed with their proposed initial public offerings (IPOs).

The Securities and Exchange Board of India (SEBI) received the draft offer documents of the four firms between May and July. The regulator issued its observations on their IPO proposals between September 28 and October 1, according to an update on Sebi's website on Thursday.

The SEBI observations mark an important step in the IPO process, allowing firms to proceed with preparations for their public issues, subject to applicable regulatory requirements.

Carlsberg India, the Indian subsidiary of Danish brewing major Carlsberg Group, had submitted confidential pre-filed draft papers with SEBI on July 1.

The confidential filing route allows firms to submit draft offer documents to markets regulator Sebi for review without immediately making commercially sensitive information public.

With this move, Carlsberg joined a growing list of multinational firms looking to tap India's equity markets. South Korean conglomerates – Hyundai Motor and LG Electronics – have already listed their Indian subsidiaries to unlock shareholder value.

Click Here To Read All IPO News

TMC Transformers (India) Ltd's proposed Rs 550-crore IPO is entirely a fresh offering of equity shares, with no offer-for-sale (OFS) component.

The firm plans to use the IPO proceeds to fund capital expenditure for setting up a greenfield Extra High Voltage (EHV) transformer manufacturing facility with an installed capacity of 78,000 MVA at Halol in Gujarat. The funds will additionally be used to meet incremental working capital requirements and for general corporate purposes.

Ujin Pharma’s proposed IPO comprises a fresh offering of 1.18 crore equity shares and an OFS of 72.82 lakh shares by promoters Jinesh Rasiklal Sheth and Umang Ketan Mehta.

Of the proceeds from the fresh offering, the Mumbai-based firm plans to invest Rs 61.7 crore in Altra Agro-Chem and Rs 21.6 crore in Altra Pharma-Chem through subscription to equity shares, making both firms its subsidiaries.

Matangi Rubber has additionally received SEBI's observations for its proposed IPO, according to the regulator's latest data.

The approval comes amid sustained activity in the primary market.